Anika Therapeutics Inc (ANIK)
25.65
+0.06
(+0.23%)
USD |
NASDAQ |
Apr 17, 16:00
25.65
0.00 (0.00%)
After-Hours: 20:00
Anika Therapeutics Cash from Financing (TTM): -6.324M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -6.324M |
| September 30, 2023 | -5.999M |
| June 30, 2023 | -10.50M |
| March 31, 2023 | -5.603M |
| December 31, 2022 | -4.852M |
| September 30, 2022 | -5.459M |
| June 30, 2022 | -7.83M |
| March 31, 2022 | -7.19M |
| December 31, 2021 | -6.779M |
| September 30, 2021 | -34.95M |
| June 30, 2021 | -53.15M |
| March 31, 2021 | -4.084M |
| December 31, 2020 | -3.774M |
| September 30, 2020 | 24.62M |
| June 30, 2020 | 71.49M |
| March 31, 2020 | -8.164M |
| December 31, 2019 | -8.142M |
| September 30, 2019 | -8.475M |
| June 30, 2019 | -30.17M |
| March 31, 2019 | -27.80M |
| December 31, 2018 | -28.90M |
| September 30, 2018 | -28.84M |
| June 30, 2018 | -28.74M |
| March 31, 2018 | -0.95M |
| December 31, 2017 | 0.314M |
| Date | Value |
|---|---|
| September 30, 2017 | 0.329M |
| June 30, 2017 | 0.294M |
| March 31, 2017 | 0.38M |
| December 31, 2016 | -23.99M |
| September 30, 2016 | -24.89M |
| June 30, 2016 | -24.91M |
| March 31, 2016 | -25.16M |
| December 31, 2015 | 1.074M |
| September 30, 2015 | 3.017M |
| June 30, 2015 | 2.914M |
| March 31, 2015 | 1.726M |
| December 31, 2014 | 5.332M |
| September 30, 2014 | -3.919M |
| June 30, 2014 | -1.704M |
| March 31, 2014 | -0.9466M |
| December 31, 2013 | -5.689M |
| September 30, 2013 | 2.150M |
| June 30, 2013 | -0.1707M |
| March 31, 2013 | -0.1059M |
| December 31, 2012 | -0.7589M |
| September 30, 2012 | -0.5287M |
| June 30, 2012 | -0.7697M |
| March 31, 2012 | -0.6856M |
| December 31, 2011 | -1.165M |
| September 30, 2011 | -1.383M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-53.15M
Minimum
Jun 2021
71.49M
Maximum
Jun 2020
-6.070M
Average
-6.779M
Median
Dec 2021
Cash from Financing (TTM) Benchmarks
| The Cooper Companies Inc | 116.00M |
| Staar Surgical Co | 7.415M |
| OrthoPediatrics Corp | 7.301M |
| NexGel Inc | 0.379M |
| Innovative Eyewear Inc | 6.661M |